ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,849, issued on March 24, was assigned to PRAXIS PRECISION MEDICINES INC. (Cambridge, Mass.).
"KCNT1 inhibitors and methods of use" was invented by Andrew Mark Griffin (L'lle Bizard, Canada), Gabriel Martinez Botella (Wayland, Mass.), Brian Edward Marron (Ada, Mich.) and Paul S. Charifson (Framingham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neu...